ArticleActa neuropathologica communications2013
The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma.
Kristian W Pajtler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this paperpooled itcites it